AstraZeneca is patenting (WO9932082) a way to help children and the elderly
take bulky tablets such as the asthma drug Zafirlukast, which is difficult to
swallow. Zeneca鈥檚 answer is to coat minuscule sugar or starch spheres less than
a millimetre wide with Zafirlukast and a polyvinylpyrrolidone binder. The
pellets are baked and sealed with another coating of a similar binder to conceal
the drug鈥檚 taste. The tiny pellets can then be sprinkled on food or in a drink
like sugar.
More from New Scientist
Explore the latest news, articles and features
Technology
Test moderators use AI-generated writing to judge literacy standards
News
Technology
We should decide how AI shapes the future, not tech firms
Comment
Technology
Quantum voting could make elections more secure
News
Technology
DeepMind AI gives an extra day of warning ahead of deadly cyclones
News
Popular articles
Trending New Scientist articles